Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/21/1998 | EP0871630A1 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO 3,4':4,5]FURO(3,2-b)PYRIDINE-6,8 7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES |
10/21/1998 | EP0871628A1 Quinolizinone type compounds |
10/21/1998 | EP0871627A1 Novel substituted azacyclic or azabicyclic compounds |
10/21/1998 | EP0871626A1 Novel triazolones as apolipoprotein-b synthesis inhibitors |
10/21/1998 | EP0871625A1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
10/21/1998 | EP0871624A1 Antagonists of gonadotropin releasing hormone |
10/21/1998 | EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
10/21/1998 | EP0871622A1 Novel compounds |
10/21/1998 | EP0871619A1 Phenyl thiazole derivatives with anti herpes virus properties |
10/21/1998 | EP0871616A1 Process for the preparation of anti-malarial drugs |
10/21/1998 | EP0871615A1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
10/21/1998 | EP0871614A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators |
10/21/1998 | EP0871613A1 Benzyl piperidine derivatives as pharmaceutical agents |
10/21/1998 | EP0871611A1 New derivatives of glycylanilides, preparation and therapeutical application |
10/21/1998 | EP0871608A1 Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy |
10/21/1998 | EP0871606A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
10/21/1998 | EP0871512A1 Localized intravascular delivery of growth factors for promotion of angiogenesis |
10/21/1998 | EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions |
10/21/1998 | EP0871492A2 Mesothelium antigen and methods and kits for targeting it |
10/21/1998 | EP0871491A2 Polymers |
10/21/1998 | EP0871490A1 Branched hydrazone linkers |
10/21/1998 | EP0871489A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
10/21/1998 | EP0871488A1 Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist |
10/21/1998 | EP0871487A1 Dendritic cell stimulatory factor |
10/21/1998 | EP0871485A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
10/21/1998 | EP0871481A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
10/21/1998 | EP0871475A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
10/21/1998 | EP0871473A1 Pharmaceutical composition containing il-10 |
10/21/1998 | EP0871471A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
10/21/1998 | EP0871469A1 Nisin in combination with glycerol monolaurate active against helicobacter |
10/21/1998 | EP0871465A1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
10/21/1998 | EP0871460A1 Bioactive factors of aloe vera plants |
10/21/1998 | EP0871458A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
10/21/1998 | EP0871456A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
10/21/1998 | EP0871455A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
10/21/1998 | EP0871454A1 Phosphorous-containing cysteine and serine protease inhibitors |
10/21/1998 | EP0871453A1 Combined hormonal contraception pharmaceutical preparation |
10/21/1998 | EP0871452A2 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
10/21/1998 | EP0871451A1 Stanol composition and the use thereof |
10/21/1998 | EP0871450A1 New combination |
10/21/1998 | EP0871449A1 Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits |
10/21/1998 | EP0871448A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
10/21/1998 | EP0871447A1 Water soluble camptothecin analogs |
10/21/1998 | EP0871446A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
10/21/1998 | EP0871445A1 Composition for treating pain |
10/21/1998 | EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
10/21/1998 | EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
10/21/1998 | EP0871442A1 Benzimidzolyl neuropeptide y receptor antagonists |
10/21/1998 | EP0871441A1 Dfmo and taxol for the treatment or prevention of breast cancer |
10/21/1998 | EP0871440A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
10/21/1998 | EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
10/21/1998 | EP0871438A1 Antimicrobial and anti-inflammatory compounds |
10/21/1998 | EP0871437A1 Use of boswellic acid for treating brain tumours |
10/21/1998 | EP0871436A1 USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS |
10/21/1998 | EP0871435A1 Sustained release formulation containing three different types of polymers |
10/21/1998 | EP0871434A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
10/21/1998 | EP0871432A2 Biological agent compositions |
10/21/1998 | EP0871420A1 Triacetin as a transdermal penetration enhancer |
10/21/1998 | EP0871376A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
10/21/1998 | EP0871373A1 Aliphatic amide feed supplement for ruminants |
10/21/1998 | EP0871361A1 Agent for combating parasites in farmed fish |
10/21/1998 | EP0790769A4 Eleutherobin and analogs thereof |
10/21/1998 | EP0789568A4 Antineoplastic cocoa extracts, methods for making, using |
10/21/1998 | EP0788795A4 Pharmacologically active 2-mercaptobenzimidazole derivatives |
10/21/1998 | EP0775129B1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
10/21/1998 | EP0752871A4 Adhesion inhibiting composition |
10/21/1998 | EP0739351A4 Monomeric diols and phosphate linked oligomers formed therefrom |
10/21/1998 | EP0738327B1 Host-vector system for use in gene therapy |
10/21/1998 | EP0735899A4 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages |
10/21/1998 | EP0710229B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
10/21/1998 | EP0710227B1 Vitamin d analogues |
10/21/1998 | EP0706517B1 Pyridazinone derivatives with pharmaceutical activity |
10/21/1998 | EP0661283B1 Brain cell protective |
10/21/1998 | EP0651740B1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
10/21/1998 | EP0613560B1 A method for assaying and treating alzheimer's disease |
10/21/1998 | EP0579769B1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
10/21/1998 | CN1196734A Anti-inflammatory agent |
10/21/1998 | CN1196731A Diglycosylated 1,2-diols as mimetics of sialyl-lewis X and sialyl-Lewis A analogies |
10/21/1998 | CN1196730A Novel polymorphic forms of troglitazone having enhanced anti-brabetic activity and process for their preparation |
10/21/1998 | CN1196729A Novel heterocyclic compounds |
10/21/1998 | CN1196728A Prolylendopeptidase inhibitors |
10/21/1998 | CN1196726A 4,5-diaryl oxazole derivatives |
10/21/1998 | CN1196724A Piperazine devivatives and process for preparation thereof |
10/21/1998 | CN1196720A Novel vitamin D analogues |
10/21/1998 | CN1196681A Ophthalmic preparations |
10/21/1998 | CN1196680A Endothelin receptor antagonists |
10/21/1998 | CN1196679A Method of treating colonic adenomas |
10/21/1998 | CN1196678A Di-and trivalent small molecule selecting protein inhibitors |
10/21/1998 | CN1196677A Process for preparing solid bosage forms of very low-dose drugs |
10/21/1998 | CN1196676A Ophthalamic compositions containing cyclotextrins and quatemary ammonium composition |
10/21/1998 | CN1196356A Process for preparation of moenomycin A |
10/21/1998 | CN1196348A Compound with immunodepression action |
10/21/1998 | CN1196258A Compounding method and technology for pure natural anti-senile preparation |
10/21/1998 | CN1196247A Deodorization medicine used in human intestine |
10/21/1998 | CN1196245A Application of stilbene compound and its derivative in preparation of endothelium element antagonist agent |
10/21/1998 | CN1196243A Powder agent formula for treating acne and seborrhea and preparation method |
10/21/1998 | CN1196241A Medicine for treating hypodermatorsis bovis and its preparation method |
10/21/1998 | CN1196240A Heme antianemia medicine and preparation method |
10/21/1998 | CN1196239A Skin permeation medicinal control release paster for give-up drug |
10/21/1998 | CN1040329C 15,15-diakyl-substituted derivatives of estradiol |